Antiva Biosciences Company

Antiva Biosciences, Inc. is a clinical-stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva’s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
Technology: Biotechnology, Health Care, Medical
Industry: Healthcare
Headquarters: Del Mar, California, United States
Founded Date: 2012
Employees Number: N/A
Funding Status: Late Stage Venture

Visit Website
Register and Claim Ownership